Home/Peptilogics/Ellie Hershberger, PharmD

EH

Ellie Hershberger, PharmD

Chief Development Officer

Therapeutic Areas

Infectious Disease Orthopedics

Peptilogics Pipeline

Drug	Indication	Phase
PLG0206	Prosthetic Joint Infection (PJI)	Phase 2/3

Leadership Team at Peptilogics

Jonathan Steckbeck, PhD, MBA

Nick Pachuda, DPM

Chief Operating Officer

Ian Friedland, MD

Chief Medical Officer

Nicholas Nystrom, PhD

Chief Technology Officer

View full Peptilogics profile